FTH · Faeth Therapeutics, Inc. · Investor Relations
$29.74
+1.67 (+5.95%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 4, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 4, 2026Market Cap
$723.53M
Shares
25.84M
Volume · Sep 30
356.52K
Avg daily vol (3M)
338.77K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-06 00:00 UTC | Virtual KOL Event: Multi-Nodal Inhibition for the Treatment of Endometrial Cancer | Webcast |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-16 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-09-10 | Cantor Global Healthcare Conference 2026 | Conference |
| 2026-04-16 | 25th Annual Needham Virtual Healthcare Conference | Conference |
| 2026-02-18 | Sensei Acquisition of Faeth Therapeutics | Webcast |
Source: https://investors.senseibio.com/